COL4A1 and myopathy: To test the relative impact of early versus late intervention, we evaluated ICH and myopathy severity in Col4a1+/Δex41 mice for which 4PBA was either discontinued or initiated at weaning [treated from E9.5 to postnatal day (P) 25 or from P25 to 3MO, respectively].